Benjamin Edwards Inc Embecta Corp. Transaction History

Benjamin Edwards Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$21.6 - $30.69 $86 - $122	-4 Reduced 66.67%	2 $0
Q1 2023 Apr 27, 2023	SELL	$23.07 - $32.77 $23 - $32	-1 Reduced 14.29%	6 $0
Q4 2022 Feb 07, 2023	SELL	$25.29 - $35.48 $75 - $106	-3 Reduced 30.0%	7 $0
Q3 2022 Oct 28, 2022	BUY	$24.0 - $33.42 $48 - $66	2 Added 25.0%	10 $0
Q2 2022 Aug 12, 2022	BUY	$24.78 - $33.36 $198 - $266	8 New	8 $0

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

Stay updated on Benjamin Edwards Inc with notifications on news.